Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Cerveau
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
A phase III, randomised, parallel group, multi-centre study in recurrent glioblastoma patients to compare the efficacy of cediranib [recentin™, AZD2171] monotherapy and the combination of cediranib with lomustine to the efficacy of lomustine alone.
Scientific Abstract
en cours d'intégration;